3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Sarcoma
2
Conditions
Prostatic Neoplasms
4
Sarcoma
2
Meningioma
2
Brain Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Resectable Lung Non-Small Cell Carcinoma
1
Pituitary Neoplasms
1
Pancreatic Neoplasms
1
Neurilemmoma
1
Nerve Sheath Neoplasms
1
Neoplasms
1
Ion Beam Radiation Therapy for Tumor Patients
1
Gastroesophageal Junction Adenocarcinoma
1
Clinical Stage I Esophageal Adenocarcinoma AJCC v8
1
Carcinoma, Adenoid Cystic
1
Breast Neoplasms
1
Interventions
Doxorubicin
15
pembrolizumab
12
Cyclophosphamide
9
Surgical Procedures, Operative
8
Gemcitabine
8
Blood Specimen Collection
8
Ifosfamide
7
Surveys and Questionnaires
6
Nivolumab
6
Trabectedin
5
Radiotherapy
5
Magnetic Resonance Spectroscopy
5
Drug Therapy
5
fludarabine
4
Temozolomide
4
Specimen Handling
4
Radiation Dose Hypofractionation
4
Biopsy
4
selinexor
3
pazopanib
3
liposomal doxorubicin
3
cabozantinib
3
atezolizumab
3
anlotinib
3
Radiation
3
Observation
3
Docetaxel
3
Dacarbazine
3
trastuzumab deruxtecan
2
toripalimab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Sarcoma
×
Protons
×
Clear all
NCT04946357
2026-04-06
EXTREM ION
University Hospital Heidelberg
Phase NA
Recruiting
42 enrolled
NCT02838602
2021-09-02
ETOILE
Hospices Civils de Lyon
Phase NA
Recruiting
250 enrolled